Q‐T interval (QT_C) in patients with cirrhosis: relation to vasoactive peptides and heart rate

References

• Kowalski H. J., Abelmann W. H. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953; 32: 1025–33
   PubMed Web of Science ®Google Scholar
• Henriksen J. H. Systemic haemodynamic alterations in hepatic cirrhosis. Eur J Gastroenterol Hepatol 1991; 3: 705–13
   Web of Science ®Google Scholar
• Groszmann R. J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359–63
   PubMed Web of Science ®Google Scholar
• Møller S., Henriksen J. H. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9–15
   PubMed Web of Science ®Google Scholar
• Ma Z., Lee S. S. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451–9
   PubMed Web of Science ®Google Scholar
• Day C. P., James O. F., Butler T. J., Campbell R. W. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993; 341: 1423–8
   PubMed Web of Science ®Google Scholar
• Mohamed R., Forsey P. R., Davies M. K., Neuberger J. M. Effect of liver transplantation on Q–T interval prolongation and autonomic dysfunction in end‐stage liver disease. Hepatology 1996; 23: 1128–34
   PubMed Web of Science ®Google Scholar
• Bernardi M., Clandra S., Colantoni A., Trevisani F., Raimondo M. L., Sica G., et al. QT interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998; 27: 28–34
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Fuglsang S., Bendtsen F., Christensen E., Møller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002; 36: 513–20
   PubMed Web of Science ®Google Scholar
• Ytting H., Henriksen J. H., Fuglsang S., Bendtsen F., Møller S. Prolonged Q‐TC interval in mild portal hypertensive cirrhosis. J Hepatol 2005; 43: 637–44
   PubMed Web of Science ®Google Scholar
• Caligiuri A., Glaser S., Rodgers R. E., Phinizy J. L., Robertson W., Papa E., et al. Endothelin‐1 inhibits secretin‐stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. Am J Physiol 1998; 275: G835–46
   Google Scholar
• Gerbes A. L., Møller S., Gulberg V., Henriksen J. H. Endothelin‐1 and ‐3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 1995; 21: 735–9
   PubMed Web of Science ®Google Scholar
• Møller S., Gulberg V., Henriksen J. H., Gerbes A. L. Endothelin‐1 and endothelin‐3 in cirrhosis: relations to systemic and splanchnic haemodynamics. J Hepatol 1995; 23: 135–44
   PubMed Web of Science ®Google Scholar
• Møller S., Becker U., Schifter S., Abrahamsen J., Henriksen J. H. Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1996; 25: 316–28
   PubMed Web of Science ®Google Scholar
• Gulati A. Endothelin mechanisms in the heart: role in pathophysiology. Endothelin: role in health and disease, A Gulati, 1995; 193–213
   Google Scholar
• Hartleb M., Rudzki K., Karpel E., Becker A., Waluga M., Boldys H., et al. Cardiovascular status after postural change in compensated cirrhosis: an argument for vasodilatory concept. Liver 1997; 17: 1–6
   PubMedGoogle Scholar
• Puddu P. E., Jouve R., Mariotti S., Giampaoli S., Lanti M., Reale A., et al. Evaluation of 10 QT prediction formulas in 881 middle‐aged men from the seven countries study: emphasis on the cubic root Fridericia's equation. J Electrocardiol 1988; 21: 219–29
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Møller S., Schifter S., Abrahamsen J., Becker U. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene‐related peptide but not to activated vasoconstrictor systems. Gut 2001; 49: 112–8
   PubMed Web of Science ®Google Scholar
• Møller S., Gulberg V., Becker U., Gerbes A. L., Henriksen J. H. Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin‐1. Scand J Gastroenterol 2002; 37: 1064–9
   PubMed Web of Science ®Google Scholar
• Bendtsen F., Schifter S., Henriksen J. H. Increased circulating calcitonin gene‐related peptide (CGRP) in cirrhosis. J. Hepatol 1991; 12: 118–23
   PubMed Web of Science ®Google Scholar
• Møller S., Brinch K., Henriksen J. H., Becker U. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1997; 26: 1026–33
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Ring‐Larsen H., Christensen N. J. Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic intestinal sympathetic nervous activity. Gut 1987; 28: 1637–42
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Bendtsen F., Christensen N. J., Gerbes A. L., Ring‐Larsen H., Sørensen T. I. A. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta‐adrenergic blockade, and atrial natriuretic factor. Hepatology 1992; 16: 1163–70
   PubMed Web of Science ®Google Scholar
• Bendtsen F., Henriksen J. H., Sørensen T. I. A., Christensen N. J. Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic haemodynamics. J Hepatol 1990; 10: 198–204
   PubMed Web of Science ®Google Scholar
• Møller S., Wiinberg N., Henriksen J. H. Noninvasive 24‐hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995; 22: 88–95
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Winkler K. Hepatic blood flow determination – a comparison of 99mTc‐diethyl‐IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987; 4: 66–70
   PubMed Web of Science ®Google Scholar
• Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man. Acta Physiol Scand 1963; 58: 162–72
   PubMedGoogle Scholar
• Christensen P. K., Gall M‐A., Major‐Pedersen A., Sato A., Rossing P., Breum L., et al. QTc interval length and QT dispersion as predictors of mortality in patients with non‐insulin‐dependent diabetes. Scand J Clin Lab Invest 2000; 60: 323–32
   PubMed Web of Science ®Google Scholar
• Bazett H. C. An analysis of the time‐relations of electrocardiograms. Heart 1920; 7: 353–70
   Google Scholar
• Schlant R. C., Sonnenblick E. H., Katz A. M. Normal physiology of the cardiovascular system. R. W Alexander, T. C Schlant, V Fuster. McGraw‐Hill, New York 1998; 81–124, The heart, 9th edn
   Google Scholar
• Aytemir K., Maarouf N., Gallagher M. M., Yap Y. G., Waktare J. E., Malik M. Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms. Pacing Clin Electrophysiol 1999; 22: 1397–401
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Bendtsen F., Hansen E. F., Møller S. Acute non‐selective β‐adrenergic blockade reduces prolonged frequency‐adjusted Q‐T interval in patients with cirrhosis. J Hepatol 2004; 40: 239–43
   PubMed Web of Science ®Google Scholar
• Okajima M., Parent R., Thorin E., Lavallee M. Pathophysiological plasma ET‐1 levels antagonize beta‐adrenergic dilation of coronary resistance vessels in conscious dogs. Am J Physiol Heart Circ Physiol 2004; 287: H1476–83
   Web of Science ®Google Scholar
• Kiss O., Zima E., Soos P., Kekesi V., Juhasz‐Nagy A., Merkely B. Intracoronary endothelin‐1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects. Life Sci 2004; 75: 537–48
   PubMed Web of Science ®Google Scholar
• Hori N., Okanoue T., Sawa Y., Kashima K. Role of calcitonin gene‐related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats. J Hepatol 1997; 26: 1111–19
   PubMed Web of Science ®Google Scholar
• Møller S., Bendtsen F., Henriksen J. H. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scand J Gastroenterol 2005; 40: 491–500
   PubMed Web of Science ®Google Scholar
• Ahnve S., Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 1982; 65: 435–9
   PubMed Web of Science ®Google Scholar
• Cappato R., Alboni P., Pedroni P., Gilli G., Antonioli G. E. Sympathetic and vagal influences on rate‐dependent changes of QT interval in healthy subjects. Am J Cardiol 1991; 68: 1188–93
   PubMed Web of Science ®Google Scholar
• Ouriel K., Moss A. J. Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg 1995; 3: 475–8
   PubMedGoogle Scholar
• Merz C. N., Pardo Y. Mental versus physical stress, QT prolongation, and the autonomic nervous system. Circulation 2000; 101: E213–4
   Web of Science ®Google Scholar
• Henriksen J. H., Ring‐Larsen H., Christensen N. J. Circulating noradrenaline and central haemodynamics in patients with cirrhosis. Scand J Gastroentrol 1985; 20: 1185–90
   PubMed Web of Science ®Google Scholar
• Balaji S., Lau Y. R., Gillette P. C. Effects of heart rate on QT interval in children and adolescents. Heart 1997; 77: 128–9
   PubMed Web of Science ®Google Scholar